Board of Directors

Tom Lupton, Non-Executive Chairman

Tom, graduated from Oxford University in 1978 in Agriculture and Forest Sciences. After an executive career in the development and management of agriculture and forestry related enterprises largely in Africa and Asia, recently he was responsible for running a highly visible Farm Project at Sissinghurst.

Tom Lupton is a member of the Audit Committee and Chairman of the Nominations Committee, Remuneration Committee and the AIM Compliance Committee

Sean M. Smith, Chief Executive Officer

Sean has a bachelors degree in microbiology and over 25 years of experience in the speciality chemicals and industrial biotechnology industries. He has held senior commercial leadership roles ranging from sales and marketing to business management and intellectual property licensing in blue chip companies such as Ciba (now BASF) and Honeywell. In recent years, Sean has focussed on technology commercialisation through licensing and company formation working with Intellectual Ventures and several start-ups.

Alexander John Abrey, Chief Financial Officer

Alex, a Chartered Certified Accountant, joined the Board in September 2007, having been Chief Accountant to Eden for the previous four years. He has acted as Financial Director to a diverse range of businesses including a financial and management consultancy business based in Oxfordshire, a medical waste management company and an intellectual property licensee involved in plastics manufacturing. Alex has twelve years' experience in both practice and industry. Under the terms of his employment contract Alex is employed full time.

Alex Abrey is a member of the AIM Compliance Committee

Robin James Scott Cridland, Non-Executive Director

Rob currently serves as Chief Financial Officer and Company Secretary of Itaconix plc. He joined Itaconix (then Revolymer) in September 2008 from Renovo Group plc where he spent seven years as Executive Director of Finance and Business Development. He has been centrally involved in the listing of both businesses and in a number of significant licences and other product commercialisation deals. Rob has a first-class honours degree in Natural Sciences from the University of Oxford and is a Fellow of the Institute of Chartered Accountants in England and Wales.

He began his career at Coopers & Lybrand Deloitte, before moving on to senior transactional roles at Enskilda Securities and senior finance and transactional roles at GlaxoWellcome and GlaxoSmithKline. He is also currently a Governor and a Non-Executive Director of Cheadle Hulme School, Cheshire.

Rob Cridland is Chairman of the Audit Committee and a member of the Nominations Committee and the Remuneration Committee

 

 

Page last updated: 15 May 2017